Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)

Department of Health and Human Services National Institutes of Health
Tipo

Research/project funding

Posted on

Fecha de Cierre

Reference Number

PAR-23-168

The objective of this funding opportunity announcement (FOA) is to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to psychiatric disorders; and 2) to generate new insight into the biology of relevant diseases and processes that have yet to be validated as important drug targets.
Categories: Health.

More Information

Visit Website

Tipo

Research/project funding

Posted on

Fecha de Cierre

Reference Number

PAR-23-168

Estados Unidos